Lanean...
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
Classic hairy cell leukemia (HCL) is a rare indolent B‑cell-lymphoproliferative disorder, first described as a distinct disease entity in 1958. After more than two decades without effective chemotherapeutic options and a dismal prognosis of less than 5 years, only the introduction of interferon‑α (I...
Gorde:
| Argitaratua izan da: | Memo |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Vienna
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923076/ https://ncbi.nlm.nih.gov/pubmed/27429657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0269-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|